《中国康复理论与实践》

《中国康复理论与实践》 ›› 2009, Vol. 15 ›› Issue (07): 683-684.

• 临床观察 • 上一篇    下一篇

药物相关性脊髓蛛网膜炎6例报道

张皓1,2;张小年1,2;朱蓓蕾3;何静杰1,2   

  1. 1.中国康复研究中心北京博爱医院神经康复科，北京市 100068; 2.首都医科大学康复医学院，北京市 100068; 3.温州医学院附属第一医院脑血管科，浙江温州市 325000
  • 收稿日期:2009-03-09 出版日期:2009-07-01 发布日期:2009-07-01

Drug-associated Spinal Subarachnoiditis: 6 Cases Report

ZHANG Hao,ZHANG Xiao-nian,ZHU Bei-lei,et al   

  1. Department of Neurology, Capital Medical University School of Rehabilitation Medicine, Beijing Charity Hospital, China Rehabilitation Research Centre, Beijing 100068, China
  • Received:2009-03-09 Published:2009-07-01 Online:2009-07-01

PDF (PC)

摘要： 目的 探讨药物相关性脊髓蛛网膜炎的临床特点。方法 对经治的6例药物相关性脊髓蛛网膜炎患者进行回顾性分析。结果 患者均急性起病,临床以双下肢麻木、乏力、二便障碍为主要表现, 脑脊液常规表现蛋白升高明显，白细胞正常或轻度升高。结论 药物相关性脊髓蛛网膜炎一旦发生,对各种药物治疗均不敏感，预后差。在临床工作中应尽量预防其发生。

关键词: 药物相关, 脊髓蛛网膜炎, 临床表现, 预防

Abstract: Objective To explore the clinical characters of drug-associated spinal subarachnoiditis. Methods 6 patients with spinal subarachnoiditis were analyzed retrospectively. Results All the patients appeared acute onset, numbness and weakness of lower limbs, incontinence, dramatic increase of protein with normal or mild increase of WBC in cerebral fluid regulation. Conclusion Spinal subarachnoiditis, if occurs, is resistant to variety of medication, and lead to the poor outcome. Prevention is most important.

Key words: drug-associated, spinal subarachnoiditis, clinical features, prevention